-
1
-
-
31344461826
-
Sepsis in European intensive care units: results of the SOAP study
-
Vincent JL, Sakr Y, Sprung CL etal. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34:344-353.
-
(2006)
Crit Care Med
, vol.34
, pp. 344-353
-
-
Vincent, J.L.1
Sakr, Y.2
Sprung, C.L.3
-
2
-
-
77951205291
-
Contact system activation in severe infectious diseases
-
Oehmcke S, Herwald H. Contact system activation in severe infectious diseases. J Mol Med (Berl) 2010; 88:121-126.
-
(2010)
J Mol Med (Berl)
, vol.88
, pp. 121-126
-
-
Oehmcke, S.1
Herwald, H.2
-
3
-
-
84861199459
-
Sepsis: something old, something new, and a systems view
-
Namas R, Zamora R, Namas R etal. Sepsis: something old, something new, and a systems view. J Crit Care 2012; 27:e1-11.
-
(2012)
J Crit Care
, vol.27
-
-
Namas, R.1
Zamora, R.2
Namas, R.3
-
4
-
-
65349153112
-
The role of tissue factor and factor VIIa in hemostasis
-
Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 2009; 108:1447-1452.
-
(2009)
Anesth Analg
, vol.108
, pp. 1447-1452
-
-
Mackman, N.1
-
5
-
-
67849130574
-
The many faces of tissue factor
-
Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7 (Suppl. 1):136-139.
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL. 1
, pp. 136-139
-
-
Mackman, N.1
-
6
-
-
3042824612
-
The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation
-
Napoleone E, Di Santo A, Peri G etal. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol 2004; 76:203-209.
-
(2004)
J Leukoc Biol
, vol.76
, pp. 203-209
-
-
Napoleone, E.1
Di Santo, A.2
Peri, G.3
-
7
-
-
79151473567
-
Pentraxins in innate immunity: lessons from PTX3
-
Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res 2011; 343:237-249.
-
(2011)
Cell Tissue Res
, vol.343
, pp. 237-249
-
-
Deban, L.1
Jaillon, S.2
Garlanda, C.3
Bottazzi, B.4
Mantovani, A.5
-
8
-
-
34249681296
-
The role of complement C3 opsonization, C5a receptor, and CD14 in E.coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood
-
Brekke OL, Christiansen D, Fure H, Fung M, Mollnes TE. The role of complement C3 opsonization, C5a receptor, and CD14 in E.coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J Leukoc Biol 2007; 81:1404-1413.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 1404-1413
-
-
Brekke, O.L.1
Christiansen, D.2
Fure, H.3
Fung, M.4
Mollnes, T.E.5
-
9
-
-
0036721025
-
Essential role of the C5a receptor in E.coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
-
Mollnes TE, Brekke OL, Fung M etal. Essential role of the C5a receptor in E.coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002; 100:1869-1877.
-
(2002)
Blood
, vol.100
, pp. 1869-1877
-
-
Mollnes, T.E.1
Brekke, O.L.2
Fung, M.3
-
10
-
-
77955901581
-
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis
-
Silasi-Mansat R, Zhu H, Popescu NI etal. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 2010; 116:1002-1010.
-
(2010)
Blood
, vol.116
, pp. 1002-1010
-
-
Silasi-Mansat, R.1
Zhu, H.2
Popescu, N.I.3
-
11
-
-
77956057326
-
The harmful role of c5a on innate immunity in sepsis
-
Ward PA. The harmful role of c5a on innate immunity in sepsis. J Innate Immun 2010; 2:439-445.
-
(2010)
J Innate Immun
, vol.2
, pp. 439-445
-
-
Ward, P.A.1
-
12
-
-
70349469876
-
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature
-
Lappegard KT, Christiansen D, Pharo A etal. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci USA 2009; 106:15861-15866.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 15861-15866
-
-
Lappegard, K.T.1
Christiansen, D.2
Pharo, A.3
-
13
-
-
33744987414
-
Generation of C5a in the absence of C3: a new complement activation pathway
-
Huber-Lang M, Sarma JV, Zetoune FS etal. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12:682-687.
-
(2006)
Nat Med
, vol.12
, pp. 682-687
-
-
Huber-Lang, M.1
Sarma, J.V.2
Zetoune, F.S.3
-
14
-
-
79961061340
-
C1-inhibitor: more than a serine protease inhibitor
-
Zeerleder S. C1-inhibitor: more than a serine protease inhibitor. Semin Thromb Hemost 2011; 37:362-374.
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 362-374
-
-
Zeerleder, S.1
-
15
-
-
0034056242
-
C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema
-
Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2000; 52:91-112.
-
(2000)
Pharmacol Rev
, vol.52
, pp. 91-112
-
-
Caliezi, C.1
Wuillemin, W.A.2
Zeerleder, S.3
Redondo, M.4
Eisele, B.5
Hack, C.E.6
-
16
-
-
34848884555
-
Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement
-
Nielsen EW, Waage C, Fure H etal. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Mol Immunol 2007; 44:1819-1826.
-
(2007)
Mol Immunol
, vol.44
, pp. 1819-1826
-
-
Nielsen, E.W.1
Waage, C.2
Fure, H.3
-
17
-
-
0034284459
-
Proteolytic activities of two types of mannose-binding lectin-associated serine protease
-
Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000; 165:2637-2642.
-
(2000)
J Immunol
, vol.165
, pp. 2637-2642
-
-
Matsushita, M.1
Thiel, S.2
Jensenius, J.C.3
Terai, I.4
Fujita, T.5
-
18
-
-
55949106824
-
Biological activities of C1 inhibitor
-
Davis AE III, Mejia P, Lu F. Biological activities of C1 inhibitor. Mol Immunol 2008; 45:4057-4063.
-
(2008)
Mol Immunol
, vol.45
, pp. 4057-4063
-
-
Davis III, A.E.1
Mejia, P.2
Lu, F.3
-
19
-
-
38049042220
-
Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema
-
Davis AE III. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 2008; 100:S7-12.
-
(2008)
Ann Allergy Asthma Immunol
, vol.100
-
-
Davis III, A.E.1
-
20
-
-
34249749471
-
C1 inhibitor: biologic activities that are independent of protease inhibition
-
Davis AE III, Cai S, Liu D. C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology 2007; 212:313-323.
-
(2007)
Immunobiology
, vol.212
, pp. 313-323
-
-
Davis III, A.E.1
Cai, S.2
Liu, D.3
-
21
-
-
0031883545
-
Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock
-
Jansen PM, Eisele B, de Jong IW etal. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 1998; 160:475-484.
-
(1998)
J Immunol
, vol.160
, pp. 475-484
-
-
Jansen, P.M.1
de Eisele, B.2
Jong, I.W.3
-
22
-
-
84857570115
-
C1-esterase inhibitor infusion increases survival rates for patients with sepsis
-
Igonin AA, Protsenko DN, Galstyan GM etal. C1-esterase inhibitor infusion increases survival rates for patients with sepsis. Crit Care Med 2012; 40:770-777.
-
(2012)
Crit Care Med
, vol.40
, pp. 770-777
-
-
Igonin, A.A.1
Protsenko, D.N.2
Galstyan, G.M.3
-
23
-
-
70350512348
-
Coagulation and innate immune responses: can we view them separately?
-
Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood 2009; 114:2367-2374.
-
(2009)
Blood
, vol.114
, pp. 2367-2374
-
-
Delvaeye, M.1
Conway, E.M.2
-
24
-
-
77955246702
-
Anti-inflammatory effects of C1-inhibitor in porcine and human whole blood are independent of its protease inhibition activity
-
Thorgersen EB, Ludviksen JK, Lambris JD, Sfyroera G, Nielsen EW, Mollnes TE. Anti-inflammatory effects of C1-inhibitor in porcine and human whole blood are independent of its protease inhibition activity. Innate Immun 2010; 16:254-264.
-
(2010)
Innate Immun
, vol.16
, pp. 254-264
-
-
Thorgersen, E.B.1
Ludviksen, J.K.2
Lambris, J.D.3
Sfyroera, G.4
Nielsen, E.W.5
Mollnes, T.E.6
-
25
-
-
84875244143
-
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
-
Qu H, Ricklin D, Bai H etal. New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology 2013; 218:496-505.
-
(2013)
Immunobiology
, vol.218
, pp. 496-505
-
-
Qu, H.1
Ricklin, D.2
Bai, H.3
-
26
-
-
0027531731
-
Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)
-
Mollnes TE, Redl H, Hogasen K etal. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol 1993; 91:295-300.
-
(1993)
Clin Exp Immunol
, vol.91
, pp. 295-300
-
-
Mollnes, T.E.1
Redl, H.2
Hogasen, K.3
-
27
-
-
0028846781
-
A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes
-
Engstad CS, Lia K, Rekdal O, Olsen JO, Osterud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 1995; 58:575-581.
-
(1995)
J Leukoc Biol
, vol.58
, pp. 575-581
-
-
Engstad, C.S.1
Lia, K.2
Rekdal, O.3
Olsen, J.O.4
Osterud, B.5
-
28
-
-
78149481863
-
C1 inhibitor, a multi-functional serine protease inhibitor
-
Davis AE III, Lu F, Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor. Thromb Haemost 2010; 104:886-893.
-
(2010)
Thromb Haemost
, vol.104
, pp. 886-893
-
-
Davis III, A.E.1
Lu, F.2
Mejia, P.3
-
30
-
-
52049119056
-
Regulation of tissue factor procoagulant activity by post-translational modifications
-
Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res 2008; 122:831-837.
-
(2008)
Thromb Res
, vol.122
, pp. 831-837
-
-
Egorina, E.M.1
Sovershaev, M.A.2
Osterud, B.3
-
31
-
-
84863946070
-
LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression
-
Ovstebo R, Dalsbotten Aass HC, Haug F etal. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression. Innate Immun 2012; 18:580-591.
-
(2012)
Innate Immun
, vol.18
, pp. 580-591
-
-
Ovstebo, R.1
Dalsbotten Aass, H.C.2
Haug, F.3
-
32
-
-
65349105896
-
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
-
Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 2009; 69:479-491.
-
(2009)
Scand J Immunol
, vol.69
, pp. 479-491
-
-
Castellheim, A.1
Brekke, O.L.2
Espevik, T.3
Harboe, M.4
Mollnes, T.E.5
-
33
-
-
48449101517
-
Circulating tissue factor-exposing microparticles
-
Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res 2008; 122 (Suppl. 1):S47-54.
-
(2008)
Thromb Res
, vol.122
, Issue.SUPPL. 1
-
-
Lechner, D.1
Weltermann, A.2
-
34
-
-
0036314335
-
C1 inhibitor infusion modifies platelet activity in hereditary angioedema patients
-
Coppola L, Guastafierro S, Verrazzo G, Coppola A, De Lucia D, Tirelli A. C1 inhibitor infusion modifies platelet activity in hereditary angioedema patients. Arch Pathol Lab Med 2002; 126:842-845.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 842-845
-
-
Coppola, L.1
Guastafierro, S.2
Verrazzo, G.3
Coppola, A.4
De Lucia, D.5
Tirelli, A.6
-
35
-
-
79952777211
-
Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system
-
Ma YJ, Doni A, Skjoedt MO etal. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem 2011; 286:3405-3417.
-
(2011)
J Biol Chem
, vol.286
, pp. 3405-3417
-
-
Ma, Y.J.1
Doni, A.2
Skjoedt, M.O.3
-
36
-
-
0026591877
-
Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component
-
Breviario F, d'Aniello EM, Golay J etal. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267:22190-22197.
-
(1992)
J Biol Chem
, vol.267
, pp. 22190-22197
-
-
Breviario, F.1
d'Aniello, E.M.2
Golay, J.3
-
38
-
-
84856369177
-
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis
-
Benagiano M, Munari F, Ciervo A etal. Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci USA 2012; 109:1222-1227.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 1222-1227
-
-
Benagiano, M.1
Munari, F.2
Ciervo, A.3
-
39
-
-
48049089596
-
Combined inhibition of complement and CD14 abolish E.coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood
-
Brekke OL, Christiansen D, Fure H etal. Combined inhibition of complement and CD14 abolish E.coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood. Mol Immunol 2008; 45:3804-3813.
-
(2008)
Mol Immunol
, vol.45
, pp. 3804-3813
-
-
Brekke, O.L.1
Christiansen, D.2
Fure, H.3
-
40
-
-
0020004989
-
A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement
-
Ziccardi RJ. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J Immunol 1982; 128:2505-2508.
-
(1982)
J Immunol
, vol.128
, pp. 2505-2508
-
-
Ziccardi, R.J.1
-
41
-
-
0041929232
-
C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide
-
Liu D, Cai S, Gu X, Scafidi J, Wu X, Davis AE III. C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol 2003; 171:2594-2601.
-
(2003)
J Immunol
, vol.171
, pp. 2594-2601
-
-
Liu, D.1
Cai, S.2
Gu, X.3
Scafidi, J.4
Wu, X.5
Davis III, A.E.6
-
43
-
-
79953292346
-
Activation of factor VII-activating protease in human inflammation: a sensor for cell death
-
Stephan F, Hazelzet JA, Bulder I etal. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. Crit Care 2011; 15:R110.
-
(2011)
Crit Care
, vol.15
-
-
Stephan, F.1
Hazelzet, J.A.2
Bulder, I.3
-
44
-
-
78049437566
-
C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia
-
Dorresteijn MJ, Visser T, Cox LA etal. C1-esterase inhibitor attenuates the inflammatory response during human endotoxemia. Crit Care Med 2010; 38:2139-2145.
-
(2010)
Crit Care Med
, vol.38
, pp. 2139-2145
-
-
Dorresteijn, M.J.1
Visser, T.2
Cox, L.A.3
-
45
-
-
57049126264
-
The combinations C1 esterase inhibitor with coagulation factor XIII and N-acetylcysteine with tirilazad mesylate reduce the leukocyte adherence in an experimental endotoxemia in rats
-
Birnbaum J, Klotz E, Spies CD etal. The combinations C1 esterase inhibitor with coagulation factor XIII and N-acetylcysteine with tirilazad mesylate reduce the leukocyte adherence in an experimental endotoxemia in rats. Clin Hemorheol Microcirc 2008; 40:167-176.
-
(2008)
Clin Hemorheol Microcirc
, vol.40
, pp. 167-176
-
-
Birnbaum, J.1
Klotz, E.2
Spies, C.D.3
-
46
-
-
0036869137
-
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction
-
de Zwaan C, Kleine AH, Diris JH etal. Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J 2002; 23:1670-1677.
-
(2002)
Eur Heart J
, vol.23
, pp. 1670-1677
-
-
de Zwaan, C.1
Kleine, A.H.2
Diris, J.H.3
|